Well Referenced

Tag: Long-Term Pharmacotherapy

Long-Term Pharmacotherapy of Obesity 2000: A Review of Efficacy and Safety

This 2001 review analyzed long-term (≥36 weeks) placebo-controlled trials of obesity pharmacotherapy published since 1960. The study found that weight loss attributable to pharmacotherapy over 36–52 weeks was approximately 8.1% (7.9 kg) for phentermine resin, 5.0% (4.3 kg) for sibutramine, 3.4% (3.4 kg) for orlistat, and −1.5% (−1.5 kg) for

Read More »
June 26, 2025 No Comments

The Long-Term Management of Obesity with Continuing Pharmacotherapy

This 2004 case series examines the clinical experiences of eight adult patients who utilized pharmacotherapy for obesity management over a period exceeding 10 years. The medications used included agents such as phentermine and sibutramine. Patients reported sustained weight loss, perceived benefits, and an absence of significant side effects. Notably, there

Read More »
June 26, 2025 No Comments